APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal-derived Immune Globulin Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Animal-derived Immune Globulin Products Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchAnimal-derived Immune Globulin Products Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal-derived Immune Globulin Products Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Animal-derived Immune Globulin Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal-derived Immune Globulin Products Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal-derived Immune Globulin Products Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Animal-derived Immune Globulin Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Animal-derived Immune Globulin Products include Sanofi, Merck & Co, Pfizer, Rare Disease Therapeutics, BTG Specialty Pharmaceuticals and Bioclon Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Animal-derived Immune Globulin Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Animal-derived Immune Globulin Products market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Animal-derived Immune Globulin Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Animal-derived Immune Globulin Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Animal-derived Immune Globulin Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Animal-derived Immune Globulin Products Market by Company

Sanofi

Merck & Co

Pfizer

Rare Disease Therapeutics

BTG Specialty Pharmaceuticals

Bioclon Institute

Animal-derived Immune Globulin Products Segment by Type

IVIg Liquid

IVIg Powder

Animal-derived Immune Globulin Products Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Animal-derived Immune Globulin Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Animal-derived Immune Globulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IVIg Liquid Table 2. Major Company of IVIg Powder Table 3. Global Animal-derived Immune Globulin Products Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (units) Table 5. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Type (2021-2026) Table 6. Global Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (US$ Million) Table 7. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Type (2021-2026) Table 8. Global Animal-derived Immune Globulin Products Price by Type (2021-2026) & (US$/unit) Table 9. Global Animal-derived Immune Globulin Products Sales by Type (2027-2032) & (units) Table 10. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Type (2027-2032) Table 11. Global Animal-derived Immune Globulin Products Sales by Type (2027-2032) & (US$ Million) Table 12. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Type (2027-2032) Table 13. Global Animal-derived Immune Globulin Products Price by Type (2027-2032) & (US$/unit) Table 14. North America Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (units) Table 15. North America Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (units) Table 17. Europe Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (units) Table 21. Latin America Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Animal-derived Immune Globulin Products Sales by Type (2021-2026) & (US$ Million) Table 24. Animal-derived Immune Globulin Products Industry Trends Table 25. Animal-derived Immune Globulin Products Industry Drivers Table 26. Animal-derived Immune Globulin Products Industry Opportunities and Challenges Table 27. Animal-derived Immune Globulin Products Industry Restraints Table 28. Global Animal-derived Immune Globulin Products Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Animal-derived Immune Globulin Products Revenue Market Share by Company (2021-2026) Table 30. Global Animal-derived Immune Globulin Products Sales by Company (2021-2026) & (units) Table 31. Global Animal-derived Immune Globulin Products Sales Share by Company (2021-2026) Table 32. Global Animal-derived Immune Globulin Products Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Animal-derived Immune Globulin Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Animal-derived Immune Globulin Products Major Company Production Sites and Headquarters Table 35. Global Animal-derived Immune Globulin Products Company, Product Type & Application Table 36. Global Animal-derived Immune Globulin Products Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Animal-derived Immune Globulin Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Animal-derived Immune Globulin Products Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Animal-derived Immune Globulin Products Sales by Region (2021-2026) & (units) Table 41. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Region (2021-2026) Table 42. Global Animal-derived Immune Globulin Products Sales by Region (2021-2026) & (US$ Million) Table 43. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Region (2021-2026) Table 44. Global Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Animal-derived Immune Globulin Products Sales by Region (2027-2032) & (units) Table 46. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Region (2027-2032) Table 47. Global Animal-derived Immune Globulin Products Sales by Region (2027-2032) & (US$ Million) Table 48. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Region (2027-2032) Table 49. Global Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Animal-derived Immune Globulin Products Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (units) Table 52. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Application (2021-2026) Table 53. Global Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (US$ Million) Table 54. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Application (2021-2026) Table 55. Global Animal-derived Immune Globulin Products Price by Application (2021-2026) & (US$/unit) Table 56. Global Animal-derived Immune Globulin Products Sales by Application (2027-2032) & (units) Table 57. Global Animal-derived Immune Globulin Products Sales Market Share in Volume by Application (2027-2032) Table 58. Global Animal-derived Immune Globulin Products Sales by Application (2027-2032) & (US$ Million) Table 59. Global Animal-derived Immune Globulin Products Sales Market Share in Value by Application (2027-2032) Table 60. Global Animal-derived Immune Globulin Products Price by Application (2027-2032) & (US$/unit) Table 61. North America Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (units) Table 62. North America Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (units) Table 64. Europe Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (units) Table 68. Latin America Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Animal-derived Immune Globulin Products Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Animal-derived Immune Globulin Products Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sanofi Animal-derived Immune Globulin Products Product Portfolio Table 75. Sanofi Recent Development Table 76. Merck & Co Company Information Table 77. Merck & Co Business Overview Table 78. Merck & Co Animal-derived Immune Globulin Products Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck & Co Animal-derived Immune Globulin Products Product Portfolio Table 80. Merck & Co Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Animal-derived Immune Globulin Products Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer Animal-derived Immune Globulin Products Product Portfolio Table 85. Pfizer Recent Development Table 86. Rare Disease Therapeutics Company Information Table 87. Rare Disease Therapeutics Business Overview Table 88. Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Portfolio Table 90. Rare Disease Therapeutics Recent Development Table 91. BTG Specialty Pharmaceuticals Company Information Table 92. BTG Specialty Pharmaceuticals Business Overview Table 93. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Portfolio Table 95. BTG Specialty Pharmaceuticals Recent Development Table 96. Bioclon Institute Company Information Table 97. Bioclon Institute Business Overview Table 98. Bioclon Institute Animal-derived Immune Globulin Products Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Bioclon Institute Animal-derived Immune Globulin Products Product Portfolio Table 100. Bioclon Institute Recent Development Table 101. North America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 102. North America Animal-derived Immune Globulin Products Sales by Country (2021-2026) & (units) Table 103. North America Animal-derived Immune Globulin Products Sales Market Share by Country (2021-2026) Table 104. North America Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032) & (units) Table 105. North America Animal-derived Immune Globulin Products Sales Market Share Forecast by Country (2027-2032) Table 106. North America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Animal-derived Immune Globulin Products Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Animal-derived Immune Globulin Products Market Share by Country (2021-2026) Table 109. North America Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Animal-derived Immune Globulin Products Market Share Forecast by Country (2027-2032) Table 111. Europe Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 112. Europe Animal-derived Immune Globulin Products Sales by Country (2021-2026) & (units) Table 113. Europe Animal-derived Immune Globulin Products Sales Market Share by Country (2021-2026) Table 114. Europe Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032) & (units) Table 115. Europe Animal-derived Immune Globulin Products Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Animal-derived Immune Globulin Products Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Animal-derived Immune Globulin Products Market Share by Country (2021-2026) Table 119. Europe Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Animal-derived Immune Globulin Products Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Animal-derived Immune Globulin Products Sales by Country (2021-2026) & (units) Table 123. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032) & (units) Table 125. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Animal-derived Immune Globulin Products Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Animal-derived Immune Globulin Products Market Share by Country (2021-2026) Table 129. Asia-Pacific Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Animal-derived Immune Globulin Products Market Share Forecast by Country (2027-2032) Table 131. Latin America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 132. Latin America Animal-derived Immune Globulin Products Sales by Country (2021-2026) & (units) Table 133. Latin America Animal-derived Immune Globulin Products Sales Market Share by Country (2021-2026) Table 134. Latin America Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032) & (units) Table 135. Latin America Animal-derived Immune Globulin Products Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Animal-derived Immune Globulin Products Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Animal-derived Immune Globulin Products Market Share by Country (2021-2026) Table 139. Latin America Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Animal-derived Immune Globulin Products Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Animal-derived Immune Globulin Products Sales by Country (2021-2026) & (units) Table 143. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032) & (units) Table 145. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Animal-derived Immune Globulin Products Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Animal-derived Immune Globulin Products Market Share by Country (2021-2026) Table 149. Middle East and Africa Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Animal-derived Immune Globulin Products Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Animal-derived Immune Globulin Products Distributors List Table 154. Animal-derived Immune Globulin Products Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Animal-derived Immune Globulin Products Image Figure 2. Global Animal-derived Immune Globulin Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal-derived Immune Globulin Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal-derived Immune Globulin Products Sales (2021-2032) & (units) Figure 5. IVIg Liquid Image Figure 6. Global IVIg Liquid Sales YoY Growth (2021-2032) & (units) Figure 7. IVIg Powder Image Figure 8. Global IVIg Powder Sales YoY Growth (2021-2032) & (units) Figure 9. Global Animal-derived Immune Globulin Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Animal-derived Immune Globulin Products Market Share by Type 2025 VS 2032 Figure 11. North America Animal-derived Immune Globulin Products Sales Market Share in Volume by Type in 2025 Figure 12. North America Animal-derived Immune Globulin Products Sales Market Share in Value by Type in 2025 Figure 13. Europe Animal-derived Immune Globulin Products Sales Market Share in Volume by Type in 2025 Figure 14. Europe Animal-derived Immune Globulin Products Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share in Value by Type in 2025 Figure 17. Latin America Animal-derived Immune Globulin Products Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Animal-derived Immune Globulin Products Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Animal-derived Immune Globulin Products Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Autoimmune Disease Image Figure 24. Global Autoimmune Disease Sales YoY Growth (2021-2032) & (units) Figure 25. Immunodeficiency Image Figure 26. Global Immunodeficiency Sales YoY Growth (2021-2032) & (units) Figure 27. Acute Infection Image Figure 28. Global Acute Infection Sales YoY Growth (2021-2032) & (units) Figure 29. Global Animal-derived Immune Globulin Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Animal-derived Immune Globulin Products Market Share by Application 2025 VS 2032 Figure 31. North America Animal-derived Immune Globulin Products Sales Market Share in Volume by Application in 2025 Figure 32. North America Animal-derived Immune Globulin Products Sales Market Share in Value by Application in 2025 Figure 33. Europe Animal-derived Immune Globulin Products Sales Market Share in Volume by Application in 2025 Figure 34. Europe Animal-derived Immune Globulin Products Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Animal-derived Immune Globulin Products Sales Market Share in Value by Application in 2025 Figure 37. Latin America Animal-derived Immune Globulin Products Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Animal-derived Immune Globulin Products Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share in Value by Application in 2025 Figure 41. North America Animal-derived Immune Globulin Products Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 42. North America Animal-derived Immune Globulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Animal-derived Immune Globulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Animal-derived Immune Globulin Products Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 46. Europe Animal-derived Immune Globulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Animal-derived Immune Globulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Animal-derived Immune Globulin Products Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 50. Asia-Pacific Animal-derived Immune Globulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Animal-derived Immune Globulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Animal-derived Immune Globulin Products Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 54. Latin America Animal-derived Immune Globulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Animal-derived Immune Globulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Animal-derived Immune Globulin Products Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 58. Middle East and Africa Animal-derived Immune Globulin Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Animal-derived Immune Globulin Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Animal-derived Immune Globulin Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Animal-derived Immune Globulin Products Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Animal-derived Immune Globulin Products Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Sanofi
  • Merck & Co
  • Pfizer
  • Rare Disease Therapeutics
  • BTG Specialty Pharmaceuticals
  • Bioclon Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal-derived Immune Globulin Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Animal-derived Immune Globulin Products Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Animal-derived Immune Globulin Products Market by Type
  6. 1.3.1 IVIg Liquid
  7. 1.3.2 IVIg Powder
  8. 1.4 Global Animal-derived Immune Globulin Products Market Size by Type
  9. 1.4.1 Global Animal-derived Immune Globulin Products Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Animal-derived Immune Globulin Products Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Animal-derived Immune Globulin Products Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Animal-derived Immune Globulin Products Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Animal-derived Immune Globulin Products Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Animal-derived Immune Globulin Products Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Animal-derived Immune Globulin Products Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Animal-derived Immune Globulin Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Animal-derived Immune Globulin Products Industry Trends
  2. 2.2 Animal-derived Immune Globulin Products Industry Drivers
  3. 2.3 Animal-derived Immune Globulin Products Industry Opportunities and Challenges
  4. 2.4 Animal-derived Immune Globulin Products Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Animal-derived Immune Globulin Products Revenue (2021-2026)
  2. 3.2 Global Top Players by Animal-derived Immune Globulin Products Sales (2021-2026)
  3. 3.3 Global Top Players by Animal-derived Immune Globulin Products Price (2021-2026)
  4. 3.4 Global Animal-derived Immune Globulin Products Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Animal-derived Immune Globulin Products Major Company Production Sites & Headquarters
  6. 3.6 Global Animal-derived Immune Globulin Products Company, Product Type & Application
  7. 3.7 Global Animal-derived Immune Globulin Products Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Animal-derived Immune Globulin Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Animal-derived Immune Globulin Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Animal-derived Immune Globulin Products Tier 1, Tier 2, and Tier 3
4 Animal-derived Immune Globulin Products Regional Status and Outlook
  1. 4.1 Global Animal-derived Immune Globulin Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Animal-derived Immune Globulin Products Historic Market Size by Region
  3. 4.2.1 Global Animal-derived Immune Globulin Products Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Animal-derived Immune Globulin Products Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Animal-derived Immune Globulin Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Animal-derived Immune Globulin Products Forecasted Market Size by Region
  7. 4.3.1 Global Animal-derived Immune Globulin Products Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Animal-derived Immune Globulin Products Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Animal-derived Immune Globulin Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Animal-derived Immune Globulin Products by Application
  1. 5.1 Animal-derived Immune Globulin Products Market by Application
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Animal-derived Immune Globulin Products Market Size by Application
  6. 5.2.1 Global Animal-derived Immune Globulin Products Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Animal-derived Immune Globulin Products Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Animal-derived Immune Globulin Products Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Animal-derived Immune Globulin Products Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Animal-derived Immune Globulin Products Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Animal-derived Immune Globulin Products Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Animal-derived Immune Globulin Products Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Animal-derived Immune Globulin Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Animal-derived Immune Globulin Products Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck & Co
  8. 6.2.1 Merck & Co Company Information
  9. 6.2.2 Merck & Co Business Overview
  10. 6.2.3 Merck & Co Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co Animal-derived Immune Globulin Products Product Portfolio
  12. 6.2.5 Merck & Co Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Animal-derived Immune Globulin Products Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Rare Disease Therapeutics
  20. 6.4.1 Rare Disease Therapeutics Company Information
  21. 6.4.2 Rare Disease Therapeutics Business Overview
  22. 6.4.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Portfolio
  24. 6.4.5 Rare Disease Therapeutics Recent Developments
  25. 6.5 BTG Specialty Pharmaceuticals
  26. 6.5.1 BTG Specialty Pharmaceuticals Company Information
  27. 6.5.2 BTG Specialty Pharmaceuticals Business Overview
  28. 6.5.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Portfolio
  30. 6.5.5 BTG Specialty Pharmaceuticals Recent Developments
  31. 6.6 Bioclon Institute
  32. 6.6.1 Bioclon Institute Company Information
  33. 6.6.2 Bioclon Institute Business Overview
  34. 6.6.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bioclon Institute Animal-derived Immune Globulin Products Product Portfolio
  36. 6.6.5 Bioclon Institute Recent Developments
7 North America by Country
  1. 7.1 North America Animal-derived Immune Globulin Products Sales by Country
  2. 7.1.1 North America Animal-derived Immune Globulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Animal-derived Immune Globulin Products Sales by Country (2021-2026)
  4. 7.1.3 North America Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032)
  5. 7.2 North America Animal-derived Immune Globulin Products Market Size by Country
  6. 7.2.1 North America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Animal-derived Immune Globulin Products Market Size by Country (2021-2026)
  8. 7.2.3 North America Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Animal-derived Immune Globulin Products Sales by Country
  2. 8.1.1 Europe Animal-derived Immune Globulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Animal-derived Immune Globulin Products Sales by Country (2021-2026)
  4. 8.1.3 Europe Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Animal-derived Immune Globulin Products Market Size by Country
  6. 8.2.1 Europe Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Animal-derived Immune Globulin Products Market Size by Country (2021-2026)
  8. 8.2.3 Europe Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Animal-derived Immune Globulin Products Sales by Country
  2. 9.1.1 Asia-Pacific Animal-derived Immune Globulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Animal-derived Immune Globulin Products Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Animal-derived Immune Globulin Products Market Size by Country
  6. 9.2.1 Asia-Pacific Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Animal-derived Immune Globulin Products Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Animal-derived Immune Globulin Products Sales by Country
  2. 10.1.1 South America Animal-derived Immune Globulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Animal-derived Immune Globulin Products Sales by Country (2021-2026)
  4. 10.1.3 South America Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032)
  5. 10.2 South America Animal-derived Immune Globulin Products Market Size by Country
  6. 10.2.1 South America Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Animal-derived Immune Globulin Products Market Size by Country (2021-2026)
  8. 10.2.3 South America Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Animal-derived Immune Globulin Products Sales by Country
  2. 11.1.1 Middle East and Africa Animal-derived Immune Globulin Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Animal-derived Immune Globulin Products Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Animal-derived Immune Globulin Products Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Animal-derived Immune Globulin Products Market Size by Country
  6. 11.2.1 Middle East and Africa Animal-derived Immune Globulin Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Animal-derived Immune Globulin Products Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Animal-derived Immune Globulin Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Animal-derived Immune Globulin Products Value Chain Analysis
  2. 12.1.1 Animal-derived Immune Globulin Products Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Animal-derived Immune Globulin Products Production Mode & Process
  7. 12.2 Animal-derived Immune Globulin Products Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Animal-derived Immune Globulin Products Distributors
  10. 12.2.3 Animal-derived Immune Globulin Products Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst